Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2011 | 1 |
2016 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
xiaohong bai[Author]
(80 results)?
Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer.
J Clin Oncol. 2023 Nov 20;41(33):5163-5173. doi: 10.1200/JCO.22.02630. Epub 2023 Aug 30.
J Clin Oncol. 2023.
PMID: 37647576
Clinical Trial.
FBI-1 functions as a novel AR co-repressor in prostate cancer cells.
Cui J, Yang Y, Zhang C, Hu P, Kan W, Bai X, Liu X, Song H.
Cui J, et al. Among authors: bai x.
Cell Mol Life Sci. 2011 Mar;68(6):1091-103. doi: 10.1007/s00018-010-0511-7. Epub 2010 Sep 2.
Cell Mol Life Sci. 2011.
PMID: 20812024
Item in Clipboard
Treatment outcome of nimotuzumab plus chemotherapy in advanced cancer patients: a single institute experience.
Xu S, Ramos-Suzarte M, Bai X, Xu B.
Xu S, et al. Among authors: bai x.
Oncotarget. 2016 May 31;7(22):33391-407. doi: 10.18632/oncotarget.8516.
Oncotarget. 2016.
PMID: 27050148
Free PMC article.
Item in Clipboard
Cite
Cite